Coherus Oncology (CHRS) Receivables - Other (2013 - 2026)
Coherus Oncology (CHRS) reported Receivables - Other of $446000.0 for Q1 2026, down 77.1% on a YoY basis from $1.9 million in Q1 2025, and down 26.04% sequentially from $603000.0 in Q4 2025.
Coherus Oncology (CHRS) Receivables - Other (2013 - 2026) Analysis & Trends
Coherus Oncology (CHRS) has 6 years of Receivables - Other data on file, last reported at $446000.0 in Q1 2026.
- For the quarter ending Q1 2026, Receivables - Other fell 77.1% year-over-year to $446000.0; the trailing twelve-month figure through Mar 2026 stood at $446000.0 (down 77.1% YoY), and the FY2025 full-year result was $603000.0, down 94.52% from the prior year.
- Receivables - Other fell to $446000.0 in Q1 2026, from $603000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $241.3 million in Q3 2025 to a low of $446000.0 in Q1 2026.
- A 3-year average of $63.5 million and a median of $31.2 million in 2024 frame the typical range for Receivables - Other.
- Peak annual rise in Receivables - Other reached 672.23% in 2025, while the deepest fall reached 94.52% in 2025.
- Tracing CHRS's Receivables - Other over 3 years: stood at $11.0 million in 2024, then plunged by 94.52% to $603000.0 in 2025, then decreased by 26.04% to $446000.0 in 2026.
- Business Quant data shows CHRS's Receivables - Other at $446000.0 in Q1 2026, $603000.0 in Q4 2025, and $241.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Coherus Oncology | 195.05 Mn | 28.00 Mn | 8.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 446,000.00 |
| Mar 31, 2026 | 446,000.00 |
| Dec 31, 2025 | 603,000.00 |
| Dec 31, 2025 | 603,000.00 |
| Sep 30, 2025 | 241.25 Mn |
| Sep 30, 2025 | 241.25 Mn |
| Jun 30, 2025 | 114.53 Mn |
| Jun 30, 2025 | 114.53 Mn |
| Mar 31, 2025 | 1.95 Mn |
| Mar 31, 2025 | 1.95 Mn |
| Dec 31, 2024 | 11.01 Mn |
| Dec 31, 2024 | 11.01 Mn |
| Sep 30, 2024 | 31.24 Mn |
| Sep 30, 2024 | 31.24 Mn |
| Jun 30, 2024 | 138.32 Mn |
| Jun 30, 2024 | 138.32 Mn |
| Mar 31, 2024 | 32.19 Mn |
| Mar 31, 2024 | 32.19 Mn |
| Dec 31, 2017 | 908,000.00 |
| Dec 31, 2017 | 908,000.00 |